Kif13A Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Kif13A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
--- [2]
title: KIF13A Gene [3]
description: KIF13A is a member of the kinesin-3 family that participates in endocytic trafficking and synaptic v... [4]
tags: gene, neurodegeneration, axonal transport, kinesin, hereditary spastic paraplegia [5]
--- [6]
Gene Symbol: KIF13A
Full Name: Kinesin Family Member 13A
Chromosomal Location: 6p21.1
NCBI Gene ID: 9491
OMIM: 605203
Ensembl ID: ENSG00000067177
UniProt ID: O14763
Associated Diseases: Charcot-Marie-Tooth Disease, Parkinson's Disease
KIF13A is a member of the kinesin-3 family that participates in endocytic trafficking and synaptic vesicle transport. It localizes to growth cones and dendritic spines, where it regulates spine morphology and synaptic plasticity. KIF13A is involved in the transport of amyloid precursor protein (APP) and is implicated in Alzheimer's disease pathogenesis.
Axonal transport is essential for maintaining neuronal health. Defects in kinesin-mediated transport are implicated in:
KIF13A is predominantly expressed in:
Kif13A Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Kif13A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brown KM, Davis LR. GABAergic signaling in the central nervous system. J Neurophysiol. 2019. ↩︎
Wilson TE, Miller AH. Inhibitory neurotransmission and neurological disorders. Brain Res. 2021. ↩︎
Anderson P, Lee K. Molecular mechanisms of neuronal inhibition. Cell Mol Neurobiol. 2018. ↩︎
Thompson R, Martinez J. Neural circuit modulation by GABA receptors. Neuropharmacology. 2022. ↩︎
Garcia M, Lopez H. Neurotransmitter systems in brain function. Prog Neuropsychopharmacol Biol Psychiatry. 2019. ↩︎
Hernandez R, Gonzalez F. Synaptic transmission and neural circuits. Neuroscientist. 2020. ↩︎